UK NHS asked to grasp nettle of ethical medtech procurement
This article was originally published in Clinica
The UK NHS's Purchasing and Supply Agency (PASA) has issued draft guidance on ethical procurement in healthcare. The guidelines, which are subject to consultation until the end of April 2009, are intended to be voluntary.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.